Asia's "nascent capital market" needs a catalyst — but investors shouldn't be deterred from investing in the region's private ...

Karman Holdings: Another space and defense startup, Karman confidentially filed to go public in January 2025 and aims to ...

By Scott Murdoch SYDNEY (Reuters) -Chinese bubble tea drinks company Guming Holdings is aiming to raise up to $202 million in a Hong Kong initial public offering, according to regulatory filings on ...

The group, Stop Uyghur Genocide, claims the retailer's supply chain in China includes cotton produced by Uyghur forced labor.

The company, which sells under the Good me brand, is offering 158.6 million shares in a price range of HK$8.68 to HK$9.94 ...

Cybersecurity firm SailPoint said on Tuesday it was targeting a valuation of up to $11.5 billion in its initial public ...

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

Smithfield Foods' CEO Shane Smith says he hopes that everything the company has done to make working in its plants more ...

This is ESR’s first REIT in China, and comprises three stabilised logistics facilities that have an average occupancy of 90%.

Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly support late-stage clinical development of two medicines that could ...

CHINESE bubble tea drinks company Guming Holdings is aiming to raise up to US$202 million in a Hong Kong initial public ...